Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach

NCT05980260 is registered in ClinicalTrials.gov with HELP for NOWS Consortium as lead sponsor.

NCT NCT05980260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05980260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach
Lead sponsor
HELP for NOWS Consortium
Phase
Phase 3
Overall status
Completed
Start date
March 25, 2024
Completion date
July 15, 2025
Enrollment
626 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal opiate withdrawal syndrome